Magnetic field-guided targeting

Magnetic field-guided targeting" is not a molecule or receptor, but rather a drug delivery strategy that uses magnetic nanoparticles (often called magnetic-targeted carriers or MTCs) loaded with therapeutic agents. These particles are directed to specific sites in the body—such as tumors—using external magnetic fields. The approach aims to increase local drug concentration at the disease site while minimizing systemic side effects. The most common clinical application involves doxorubicin bound to iron-based carriers for cancer therapy. Key requirements for these systems include biocompatibility, biodegradability, sufficient magnetic moment, and controlled release properties. This method is still under development and faces challenges such as ensuring safety (avoiding toxicity and embolism), achieving deep tissue targeting, and scalable manufacturing[1][2][3]. Note: "Magnetic field-guided targeting" does not refer to a specific molecular target; it describes a physical method for targeted drug delivery using engineered materials and devices.

Other names

Magnetic drug targetingMagnetic-targeted carrierMDTMTCsMagnetic vehicles

Physical guidance of drug-loaded nanoparticles to target tissue using external magnetic fields[1][2][3]